www.fdanews.com/articles/166808-oncomed-to-resume-enrollment-in-cancer-drug-trials-as-fda-lifts-partial-ban
OncoMed to Resume Enrollment in Cancer Drug Trials as FDA Lifts Partial Ban
August 29, 2014
OncoMed Pharmaceuticals said the FDA lifted a partial hold on patient enrollments for three trials testing its experimental cancer drug, vantictumab.
MedCity News